Cara Therapeutics Inc. (NASDAQ: CARA)
Cara Therapeutics is a pharmaceutical company that focuses on developing innovative treatments for and pruritus- the medical term for severe itching. While their main focus is on the opioid-based CR845, they’ve also been working on a new cannabis-based treatment that could see it become even more successful.
While opioids come with many potential side effects, cannabinoid-based medications are much safer with no fatal risks. Cara Therapeutics is currently working on a cannabinoid-receptor agonist- CR701. While research is still in the early stages, it’s become a popular stock for marijuana investors. It may be risky to invest in Cara Therapeutics while its cannabinoid-based medication is still in the preclinical-stage, but this is still a stock that’s worth considering for marijuana investors.
OrganiGram Holdings (NASDAQ: OGI)
OrganiGram Holdings is a major cannabis company and by far one of the best marijuana stocks you can find on the NASDAQ. OrganiGram produces a range of cannabis strains and products for both medical and recreational users. And, while their stock value has dropped significantly over the past year, there are many reasons why this might be one of the best marijuana stock investments right now.
Many marijuana companies have been hit by the COVID crisis, but there’s still the potential to bounce back as things return to normal. OrganiGram Holdings shows much promise as it focuses on cost-efficiency with some of the lowest cultivation costs in the cannabis industry. OrganiGram currentl from a major growth facility and has received many positive reviews on its products.
As well as producing a range of popular cannabis strains, OrganiGram Holdings also develops alternative products such as marijuana-infused edibles, vapes, and powders which all help the company to expand its range. Although the company hasn’t performed particularly well this year, its low stock price right now makes it a very attractive long-term investment.
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
Arena Pharmaceuticals, Inc. is another one of the top marijuana stocks on the NASDAQ, especially if you’re interested in investing in a cannabis-related biopharmaceutical company rather than cannabis retailers or growers. Arena Pharmaceuticals operates out of San Diego, California, and produces a wide range of medical products, including an upcoming cannabinoid-based drug.
The company is currently working on APD371 or “Olorinab”, an agonist of cannabinoid receptors with the potential to treat Crohn’s disease. The drug is designed to help patients relieve symptoms such as gastrointestinal pain but does not or produce. So far, the drug has performed well in clinical trials.
While many marijuana stocks have performed poorly throughout 2019, Arena Pharmaceuticals, Inc. stock is at its highest point in years. What’s more, the stock has the opportunity to grow even more, especially with the huge demand for cannabinoid-based treatments even in countries where cannabis is still illegal. This is a stock that you should consider investing in sooner rather than later.
Greenlane Holdings Inc. (NASDAQ: GNLN)
Marijuana growers, retailers, and pharmaceutical companies aren’t the only types of businesses that are important to the industry. Many cannabis users also need devices and accessories such as bongs, vaporizers, pipes, grinders, and more. Greenlane Holdings is one of the top marijuana companies offering these.
Greenlane Holdings has a wide range of brands offering all kinds of with some of the most prominent being Marley Naturals, Vibes, and Groove. They also act as distributors for major brands like JUUL, PAX, Raw, Bic, and more. The products they produce and distribute will always be in demand for cannabis users and their strong portfolio makes them a force to be reckoned with.
The company had much success last year, especially with the widespread sales of vaporizers and e-cigarettes including the popular JUUL device. Greenlane originally conducted an IPO on the NASDAQ a little over a year ago and, although the stock has dropped, it’s starting to bounce back, and now could be a good time to invest.
New Age Beverages Corp. (NASDAQ: NBEV)
While not inherently a marijuana stock, New Age Beverages Corp. poses another interesting opportunity for enthusiastic marijuana investors. New Age Beverages is a company that develops a range of health drinks kombucha, and many other drinks. However, the company recently became of interest to marijuana investors when it brought out a line of CBD-infused drinks.
CBD is a non-psychoactive cannabinoid that has become a popular alternative to cannabis for many users, especially since it’s legal in states where marijuana isn’t. Many consumers now actively seek out , Edibles, and Drinks, hence why New Age Beverages Corp is an attractive stock for marijuana investors.
The company saw a surge in its stock after announcing its line of CBD drinks and, although the due to regulatory uncertainties, the stock will likely experience another surge if clearance is given by the FDA. What’s more, New Age Beverages Corp. also has other lines of health drinks to fall back on- especially with the recent health concerns brought about by coronavirus. As such, this is a great stock to add to your portfolio.
If you’re interested in investing in marijuana stocks, these are some of the best stocks to look into right now. Whether you’re interested in growers, retailers, biotech companies, or ancillary businesses, there are many good options. However, keep in mind there are always risks to investing and you should do thorough research before you invest your money.
Investing in marijuana companies right now is a good idea since the industry is set to grow. Marijuana is now more accepted than ever- especially in Canada where you can now buy weed in stores and online. If you’re simply interested in buying marijuana, you can find all of the products you need on our site